Scholarly Index
Tawanda Gumbo
490 BioTech (United States); 11,171 total citations; 223 total publications; best world rank #124
490 BioTech (United States)
11,171Total citations
223Total publications
58H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Tuberculosis Research and Epidemiology | Lifetime | 203 | US 80 | 99.15 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 191 | US 86 | 98.91 |
| Mycobacterium research and diagnosis | Lifetime | 278 | US 103 | 98.45 |
| Pneumonia and Respiratory Infections | Lifetime | 660 | US 264 | 97.86 |
| Cancer therapeutics and mechanisms | Lifetime | 759 | US 385 | 96.42 |
| Antifungal resistance and susceptibility | Lifetime | 786 | US 290 | 96.40 |
| Biosimilars and Bioanalytical Methods | Lifetime | 307 | US 107 | 95.02 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 912 | US 378 | 95.88 |
| Infectious Diseases and Mycology | Lifetime | 566 | US 220 | 93.73 |
| Mycobacterium research and diagnosis | 2021-2025 | 149 | US 37 | 94.68 |
| Tuberculosis Research and Epidemiology | 2021-2025 | 261 | US 60 | 95.86 |
| Quinazolinone synthesis and applications | 2021-2025 | 124 | US 10 | 85.43 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 715 | US 132 | 84.41 |